Ohio – As part of a select group of 25 national clinical sites, The
Ohio State University Medical Center and Nationwide Children’s Hospital have received a seven-year
grant supporting clinical trials for neurologic diseases.
National Institute of Health (NIH) has created a Network of Excellence in Neuroscience
Clinical Trials (NeuroNEXT) program that fosters the cooperation needed
between sites across the country to conduct timely trials. The first meeting of
all NeuroNEXT principal investigators is scheduled for Nov. 18 at the NIH headquarters
in Bethesda, Maryland.
“The program promises
to fundamentally alter how neurologic trials are performed in this country by increasing
the efficiency and quality of studies while reducing the costs of trials,” said
Dr. John Kissel, program director
in the division of neuromuscular medicine at
Ohio State Medical Center and principal investigator for the project. “The
award recognizes the unique and extensive basic, translational and clinical
neuroscience research done at Ohio State, and the depth and breadth of experience
represented by the neuroscience faculty.”
collaboration by connecting centers studying the same disease to improve future
trials for patients. It allows clinical sites to efficiently design and
implement pediatric and adult clinical trials encompassing the entire spectrum
of neurologic diseases. Clinical sites will be able to consolidate resources, integrating
the efforts and components of experienced neuroscience clinical trial groups
more fully into existing initiatives.
The program will
build on the comprehensive research through The Ohio State University Center
for Clinical and Translational Science, the Department of Neuroscience at the
Ohio State College of Medicine, and the Departments of Neurology
and Neurological Surgery at Ohio State and Nationwide Children’s. Co-principal
in the NeuroNEXT program include Dr. Ali Rezai at The Ohio State
University Medical Center and Dr. Steve Roach at Nationwide
# # #
for a high quality JPEG of Dr. John Kissel.
Click here for video
comments from Dr. John Kissel.
Contact: Gina Bericchia, Medical Center Public Affairs and Media Relations,
614-293-3737, or Gina.Bericchia@osumc.edu